Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
AMGN Today - Aug 13: Steady Day for Amgen
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
So, what went down? Amgen’s stock price closed at around 417.75. Yeah, not a wild ride at all—just kind of floated along. Volume was steady, matching its average, which means folks weren’t rushing to buy or sell like crazy. It’s like everyone was just hanging out, not too worried.
Now, why did it stay so steady? Well, there’s some chatter about Amgen’s recent performance. They posted strong Q2 results and even raised their guidance for 2026. That’s usually a good sign, right? But here’s the kicker: some analysts are saying it might be fully valued now. So, while the numbers look solid, there’s a bit of caution in the air. People are trying to figure out if it’s worth chasing after or if it’s already priced in. Also, Daiwa Securities just bumped their price target to $430 from $390, which is a bit of a boost, but again, it’s all about how investors feel about that valuation.
Oh, and just a little nugget for you—Tema ETFs just increased their stake in Amgen. So, some folks are still feeling good about it, even if the stock’s taking a breather today.
That’s the scoop! Amgen’s playing it cool, and while there’s some optimism with the earnings and guidance, there’s also that nagging feeling about whether it’s peaked. Just remember, this is all for fun and info—no financial advice here. Catch you later!
adbl_web_anon_alc_button_suppression_t1
No reviews yet